$ALNT

Allient (NASDAQ:ALNT) reported Q2 CY2026 results. Revenue rose 10.2% year on year to $153.8 million, exceeding Wall Street estimates by 5.5%. Non-GAAP adjusted EPS was $0.80, up from $0.57 a year earlier and above consensus. Analysts expect revenue growth of 6.3% over the next 12 months and full-year EPS to rise from $2.44 to $2.91.

Allient Inc. (Nasdaq: ALNT) announced the release of its ThruSight-Theta continuous rotation rotary stage for high-precision motion uses. The product features an ironless axial flux motor for zero cogging, a 110 mm through-hole aperture, and a 25 mm profile, with optional analog and encoder feedback options.

Allient (NASDAQ: ALNT), a precision motion systems company, is set to report Q2 results Wednesday. It previously reported revenue of $138.9M, up 4.6% YoY, but missed EBITDA and EPS estimates. For the upcoming quarter, analysts expect revenue growth of 4.4% YoY. The article cites an average analyst price target of $76.80 versus $90.22 current.

US stocks rose on optimism about US-Iran peace and supportive earnings. Bloomberg Intelligence said 83% of 475 S&P 500 Q1 reporters beat estimates; Q1 earnings are projected +12% y/y (ex-tech about +3%). S&P gains were led by chip/AI and airlines as WTI fell ~3%. Rates: 10-year yield fell ~7.5 bp to 4.483%; ECB swaps price a 91% chance of a +25 bp hike.

Allient Inc. has released a new whitepaper titled "A Selection Guide to Motors for Humanoid Robotics Systems," detailing key considerations for motor selection in humanoid robotics. The whitepaper covers various motor technologies, core performance factors like torque density and thermal constraints, and system-level challenges. Robert Mastromattei, Allient's chief commercial officer, emphasized the direct impact of motor selection on humanoid system performance.

Allspring Global Investments Holdings LLC reduced its stake in Allient Inc. by 22.1% in the fourth quarter, selling 87,070 shares and now owning 306,325 shares valued at $16.47 million. Despite this, other major institutions like Vanguard and Marshall Wace have increased their holdings, with institutional investors collectively owning 61.57% of the stock. Analysts are mixed with a "Hold" consensus and a $63.60 target, while Allient recently surpassed quarterly earnings estimates and trades around $60.54.

Allient Inc. (NASDAQ:ALNT) declared a quarterly dividend of $0.03 per share, payable on April 3rd to shareholders of record on March 20th, representing an annualized yield of 0.2%. The company's dividend is well-covered by earnings, with a payout ratio of 5.4%, and analysts project continued coverage with a future payout ratio of 6.6%. Allient also reported strong quarterly earnings, beating analyst estimates with $0.55 EPS compared to $0.46, and revenue exceeding expectations at $143.35 million.

Allient Inc. reported strong Q4 2025 results with increased sales and net income, alongside a new dividend and significant insider buying. The company's "Simplify to Accelerate Now" program is boosting margins and cost controls, potentially reshaping its risk-reward profile, though high valuation and debt remain considerations. Analysts have varied price targets, with Simply Wall St's model suggesting a 21% downside to its current price despite optimistic earnings forecasts from some.

Handelsbanken Fonder AB recently purchased 131,570 shares of Allient Inc. (NASDAQ:ALNT) for approximately $5.89 million, representing 0.78% of the company. Other institutional investors, including Vanguard Group Inc., also increased their holdings. Wall Street analysts currently give Allient a "Hold" rating with an average price target of $57.50, significantly below its current trading price of $65.25.

Seizert Capital Partners LLC reduced its stake in Allient Inc. by 12.5% in the third quarter, while institutional investors collectively own 61.57% of the company. Additionally, a VP at Allient sold a significant number of shares, decreasing his position by over 40%. Allient currently trades with a market cap of $1.04 billion, a PE ratio of 54.58, and has a "Hold" consensus analyst rating with an average price target of $50.33.